BACKGROUND: Many people with diabetes continue to smoke despite being at high risk of cardiovascular disease. We examined the impact of a pay-for-performance incentive in the United Kingdom introduced in 2004 as part of the new general practitioner contract to improve support for smoking cessation and to reduce the prevalence of smoking among people with chronic diseases such as diabetes. METHODS: We performed a population-based longitudinal study of the recorded delivery of cessation advice and the prevalence of smoking using electronic records of patients with diabetes obtained from participating general practices. The survey was carried out in an ethnically diverse part of southwest London before (June-October 2003) and after (November 2005-January 2006) the introduction of a pay-for-performance incentive. RESULTS: Significantly more patients with diabetes had their smoking status ever recorded in 2005 than in 2003 (98.8% v. 90.0%, p <0.001). The proportion of patients with documented smoking cessation advice also increased significantly over this period, from 48.0% to 83.5% (p < 0.001). The prevalence of smoking decreased significantly from 20.0% to 16.2% (p < 0.001). The reduction over the study period was lower among women (adjusted odds ratio 0.71, 95% confidence interval 0.53-0.95) but was not significantly different in the most and least affluent groups. In 2005, smoking rates continued to differ significantly with age (10.6%-25.1%), sex (women, 11.5%; men, 20.6%) and ethnic background (4.9%-24.9%). INTERPRETATION: The introduction of a pay-for-performance incentive in the United Kingdom increased the provision of support for smoking cessation and was associated with a reduction in smoking prevalence among patients with diabetes in primary health care settings. Health care planners in other countries may wish to consider introducing similar incentive schemes for primary care physicians.
BACKGROUND: Many people with diabetes continue to smoke despite being at high risk of cardiovascular disease. We examined the impact of a pay-for-performance incentive in the United Kingdom introduced in 2004 as part of the new general practitioner contract to improve support for smoking cessation and to reduce the prevalence of smoking among people with chronic diseases such as diabetes. METHODS: We performed a population-based longitudinal study of the recorded delivery of cessation advice and the prevalence of smoking using electronic records of patients with diabetes obtained from participating general practices. The survey was carried out in an ethnically diverse part of southwest London before (June-October 2003) and after (November 2005-January 2006) the introduction of a pay-for-performance incentive. RESULTS: Significantly more patients with diabetes had their smoking status ever recorded in 2005 than in 2003 (98.8% v. 90.0%, p <0.001). The proportion of patients with documented smoking cessation advice also increased significantly over this period, from 48.0% to 83.5% (p < 0.001). The prevalence of smoking decreased significantly from 20.0% to 16.2% (p < 0.001). The reduction over the study period was lower among women (adjusted odds ratio 0.71, 95% confidence interval 0.53-0.95) but was not significantly different in the most and least affluent groups. In 2005, smoking rates continued to differ significantly with age (10.6%-25.1%), sex (women, 11.5%; men, 20.6%) and ethnic background (4.9%-24.9%). INTERPRETATION: The introduction of a pay-for-performance incentive in the United Kingdom increased the provision of support for smoking cessation and was associated with a reduction in smoking prevalence among patients with diabetes in primary health care settings. Health care planners in other countries may wish to consider introducing similar incentive schemes for primary care physicians.
Authors: Edward F Ellerbeck; Won S Choi; Kevin McCarter; Denise G Jolicoeur; Allen Greiner; Jasjit S Ahluwalia Journal: Prev Med Date: 2003-04 Impact factor: 4.018
Authors: A M Malarcher; E S Ford; D E Nelson; J H Chrismon; P Mowery; R K Merritt; W H Herman Journal: Diabetes Care Date: 1995-05 Impact factor: 19.112
Authors: Olaf von dem Knesebeck; Anke Hoehne; Carol Link; Lisa Marceau; Ann Adams; Martin Roland; Stephen Campbell; Johannes Siegrist; John McKinlay Journal: Patient Educ Couns Date: 2012-05-15
Authors: Christine E Sheffer; Michael Anders; S Laney Brackman; Michael B Steinberg; Claudia Barone Journal: Am J Med Sci Date: 2012-05 Impact factor: 2.378
Authors: Marie Blanquet; Laurent Gerbaud; Chantal Noirfalise; Pierre Michel Llorca; Claude Campagne; Jacques Malaval Journal: Br J Gen Pract Date: 2011-01 Impact factor: 5.386
Authors: Pieter Van Herck; Delphine De Smedt; Lieven Annemans; Roy Remmen; Meredith B Rosenthal; Walter Sermeus Journal: BMC Health Serv Res Date: 2010-08-23 Impact factor: 2.655